The Regulatory Affairs Office offers special expertise in FDA regulations, including Investigational New Drug (IND) or Investigational Device Exemptions (IDE) applications, as well as consultation with liaisons from the Research Compliance Unit, Legal Contract Administration, the Institutional Review Board (IRB) and other institutional resources.